Q1 2024 · 13F-HR
Pennant Investors, LPholdings as filed
Filed 2024-05-15 · accession 0000919574-24-003124
$403.7M
Reported value
45
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 023135106 | AMZN | AMAZON COM INC | $53.4M | 13.2% | 296,000 | Common | SOLE |
| 893641100 | TDG | TRANSDIGM GROUP INC | $51.7M | 12.8% | 42,000 | Common | SOLE |
| 594918104 | MSFT | MICROSOFT CORP | $47.1M | 11.7% | 112,000 | Common | SOLE |
| 595112103 | MU | MICRON TECHNOLOGY INC | $36.1M | 8.94% | 306,000 | Common | SOLE |
| 03674X106 | AR | ANTERO RESOURCES CORP | $32.9M | 8.14% | 1,133,000 | Common | SOLE |
| 278768106 | SATS | ECHOSTAR CORP | $30.7M | 7.60% | 2,153,209 | Common | SOLE |
| 02079K305 | GOOGL | ALPHABET INC | $30.0M | 7.44% | 199,000 | Common | SOLE |
| 037833100 | AAPL | APPLE INC | $27.4M | 6.80% | 160,000 | PUT | SOLE |
| 194014502 | ENOV | ENOVIS CORPORATION | $25.0M | 6.19% | 400,000 | Common | SOLE |
| 88337F105 | ODP1 | THE ODP CORP | $21.2M | 5.26% | 400,000 | Common | SOLE |
| L7579L106 | — | PERIMETER SOLUTIONS SA | $17.1M | 4.23% | 2,300,000 | Common | SOLE |
| 03674X106 | AR | ANTERO RESOURCES CORP | $14.5M | 3.59% | 500,000 | CALL | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $1.8M | 0.45% | 768,400 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $1.7M | 0.42% | 170,900 | Common | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $1.1M | 0.28% | 109,800 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $1.1M | 0.27% | 146,100 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $834,960 | 0.21% | 56,800 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $644,736 | 0.16% | 43,800 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $626,285 | 0.16% | 64,900 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $612,846 | 0.15% | 35,100 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $573,948 | 0.14% | 128,400 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $517,980 | 0.13% | 44,500 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $510,624 | 0.13% | 32,400 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $447,456 | 0.11% | 23,700 | Common | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $442,387 | 0.11% | 13,100 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $441,524 | 0.11% | 15,100 | Common | SOLE |
| 761299AB2 | TVTX 2.5 09/15/25 | TRAVERE THERAPEUTICS INC | $430,218 | 0.11% | 55,800 | Common | SOLE |
| 37427G101 | GETR | GETAROUND INC | $413,883 | 0.10% | 1,348,153 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $407,124 | 0.10% | 38,700 | Common | SOLE |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $401,759 | 0.10% | 168,100 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $394,020 | 0.10% | 199,000 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $351,920 | 0.09% | 42,400 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $342,372 | 0.08% | 166,200 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $327,950 | 0.08% | 17,500 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $288,234 | 0.07% | 60,300 | Common | SOLE |
| 00847G705 | AGENEUR | AGENUS INC | $272,368 | 0.07% | 469,600 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $252,200 | 0.06% | 48,500 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $249,185 | 0.06% | 30,500 | Common | SOLE |
| 09075P105 | BTAIEUR | BIOXCEL THERAPEUTICS INC | $236,598 | 0.06% | 83,900 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $234,486 | 0.06% | 186,100 | Common | SOLE |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $226,269 | 0.06% | 292,300 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $162,832 | 0.04% | 215,700 | Common | SOLE |
| 00951K104 | — | AIRSPAN NETWORKS HOLDINGS IN | $118,364 | 0.03% | 1,047,473 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $111,872 | 0.03% | 87,400 | Common | SOLE |
| G4124C117 | GRABW | GRAB HOLDINGS LIMITED | $16,208 | 0.00% | 80,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.